Semaglutide 20mg
R1,200.00
NEXT-GENERATION RESEARCH PEPTIDE
Semaglutide is a GLP-1 receptor agonist widely researched for its potential effects on appetite regulation, metabolic health, blood sugar control, and weight-management pathways. It has gained significant attention for its possible role in supporting reduced appetite, improved satiety, metabolic efficiency, and long-term body composition management.
INCLUDED IN YOUR ORDER
- 1 x 20mg Vial of Semaglutide
- 5 x 1ml Disposable Insulin syringes with needles
- 1 x Bacteriostatic Water Vial
Peptide Labs South Africa supplies high-purity Semaglutide 20mg in lyophilized form for research purposes only.
- Add 2ml bacteriostatic water to the vial.
-
This will provide the following approximate concentrations:5 units (0.05ml) = 0.5mg10 units (0.1ml) = 1mg15 units (0.15ml) = 1.5mg20 units (0.2ml) = 2mg
Allow the peptide to dissolve gently. Avoid shaking aggressively.
Inject subcutaneously into the abdomen. Rotate injection sites regularly. Best administered on the same day each week.
Suggested Weekly Dosage Schedule/Injection Protocol*
Weeks 1–4
0.5mg once weekly
5 units on an insulin syringe
Weeks 5–8
1mg once weekly
10 units on an insulin syringe
Weeks 9–12
1.5mg once weekly
15 units on an insulin syringe
Weeks 13–16
2mg once weekly
20 units on an insulin syringe
Only increase dosage if well tolerated.
Before Reconstitution:
- Store in a cool, dry place
- Refrigeration recommended for optimal stability
- After Reconstitution
- Store refrigerated at 2–8°C
- Avoid direct sunlight and heat exposure
- Do not freeze
- Best used within 30–60 days
Break / Maintenance Phase
After completing a full cycle, some protocols include:
- a 2–4 week break, or
- a lower-dose maintenance phase before restarting.
- This approach may help support long-term appetite-regulation pathways and reduce adaptation over time.
Discover the benefits of Semaglutide 20mg for weight loss in South Africa.
Research Peptide:
Research suggests that Semaglutide may help regulate hunger signalling and gastric emptying pathways, contributing to increased feelings of fullness and reduced caloric intake. Due to its long active duration, Semaglutide is commonly utilised in once-weekly administration protocols with gradual dose progression.
Potential Research Areas
- Appetite regulation research
- Weight-management support pathways
- Metabolic health research
- Blood sugar regulation pathways
- Satiety and hunger signalling research
- Body composition research
- GLP-1 receptor pathway research
- Long-term metabolic efficiency studies
Common Notes
Some individuals may experience:
-
nausea,
-
reduced appetite,
-
bloating,
-
reflux,
-
constipation,
-
or digestive discomfort,
-
particularly during the early stages of dose escalation.
Protocols commonly recommend:
- gradual dose progression,
- adequate hydration,
- smaller meal sizes,
- avoiding heavy high-fat meals,
- and maintaining consistent weekly administration.
- These effects are commonly reported during adjustment phases and may improve over time.
Disclaimer
- For research purposes only
- Not intended to diagnose, treat, cure, or prevent any disease
- Not medical advice
- Use sterile procedures when handling peptides
